Sep 26, 2014, 00:00 AM by Michael Croft

PHILADELPHIA, PA, UNITED STATES - Sep 26, 2014 - The Intellectual Property &  Science business of Thomson Reuters, the world leader in intelligent information for businesses and professionals, announced its 2014 “Nobel-class” Citation Laureates  today

Sep 25, 2014, 13:35 PM by Michael Croft

Bio-IT World News Brief | Just two days after launching a Kickstarter campaign to start the world's first brokerage service for personal whole genome sequencing, GeneHub has pulled the plug.

Sep 25, 2014, 09:35 AM by Michael Croft

Bio-IT World News Brief | Francis de Souza, president of gene sequencing company Illumina, spoke at the EmTech conference in Cambridge this week about his company's pivot to clinical use, and a growing market for whole genome sequencing that he says will produce 228,000 whole human genomes in 2014 alone.

Sep 25, 2014, 00:00 AM by Michael Croft

TORONTO, CANADA - Sep 25, 2014 - Chemical libraries for a long time have been a cornerstone in the search for new pharmaceutical compounds

Sep 24, 2014, 08:55 AM by Michael Croft

Bio-IT World News Brief | San Francisco-based GeneHub has plans to become the first company selling whole genome sequences to all comers, and launched a Kickstarter campaign this week to raise the funds it needs to get started.

Sep 24, 2014, 00:00 AM by Michael Croft

NEEDHAM, MA - Sep 24, 2014 - Cambridge Healthtech Institute Announces the Acquisition of OpenHelixProvider of online and onsite bioinformatics training to join Cambridge Healthtech Institute as division of Bio-IT World Cambridge Healthtech Institute (CHI) announced the purchase of Washington-based OpenHelix, the provider of online and onsite training on some of the most popular and powerful open-access bioinformatics resources on the web

Sep 24, 2014, 00:00 AM by Michael Croft

BISHOP'S STORTFORD, UK - Sep 24, 2014 - ~~Dotmatics, a leading provider of scientific informatics solutions and services, announced today that this year’s European User Group Meeting (EUGM) held at Down Hall Country House Hotel, Hertfordshire was the largest and most successful to date

Sep 23, 2014, 12:15 PM by Michael Croft

Clinical Informatics News | As the FDA extends its oversight to tests designed and performed in a single laboratory, diagnostic companies are celebrating a more even playing field. But hospital and academic labs worry that the high price tag of FDA review will stifle their in-house tests without protecting patients.

Sep 23, 2014, 00:00 AM by Michael Croft

NEW YORK, NY, UNITED STATES - Sep 23, 2014 - Mumbai, India - September 15, 2014 - Various technological advancements and innovations have led to an increase in the extraction of shale oil from oil reserves in the US

Sep 22, 2014, 12:55 PM by Michael Croft

Fierce Biotech | Fierce Biotech has unveiled its hotly-anticipated Fierce 15, an annual list of biotech companies showing special promise in delivering transformative new therapies.

Sep 22, 2014, 00:00 AM by Michael Croft

BILLERICA, MA - Sep 22, 2014 -  RainDance Technologies, Inc., a genomics tools company simplifying the analysis of complex genetic diseases, today announced the appointment of Frederick (Fritz) L

Sep 19, 2014, 00:00 AM by Michael Croft

RESEARCH TRIANGLE PARK, NC, UNITED STATES - Sep 19, 2014 - For Cloud Pharmaceuticals, Inc., a therapeutics company focused on cloud-based drug design and development, partnering is an integral part of its business strategy

Sep 18, 2014, 08:35 AM by Michael Croft

Bio-IT World | Contributed Commentary | As personalized medicine opens up new possibilities in cancer immunotherapy, quantified image analysis is a promising route to discovering biomarkers that can meaningfully stratify patients for treatment.

Sep 17, 2014, 09:30 AM by Michael Croft

MIT Technology Review | Oxford Nanopore, and the early access users of its MinION nanopore sequencer, share details about the device's accuracy, read length, applications, and a forthcoming high throughput instrument.

Sep 17, 2014, 00:00 AM by Michael Croft

RESEARCH TRIANGLE PARK, NC, UNITED STATES - Sep 17, 2014 - The In Silico Drug Discovery Conference today announced speakers and presentation topics that will be featured at the conference, which takes place at North Carolina Biotechnology Center’s Hamner Conference Center on December 3 and 4, 2014

Sep 15, 2014, 10:35 AM by Michael Croft

Bio-IT World | Genentech combed through its trove of thousands of cell lines to create a definitive phenotypic and genetic profile of each, making it possible to trace back preclinical experiments and share results company-wide. The project won the company its second straight Bio-IT World Best Practices Award for finding new efficiencies in its preclinical pipeline.

Sep 15, 2014, 00:00 AM by Michael Croft

PHILADELPHIA, PA, UNITED STATES - Sep 15, 2014 - The Intellectual Property and Science business of Thomson Reuters, the world's leading source of intelligent information for businesses and professionals, today announced the 150th anniversary of the Zoological Record, the oldest continuous bibliographic database in life sciences and the leading and most comprehensive source for biodiversity, systematics and zoological information

Sep 12, 2014, 06:50 AM by Michael Croft

Nature News | While the human microbiome has been mined as a source of novel therapies for years — through probiotics or fecal transplantation — a team at UC San Francisco is now exploring whether more traditional drugs could be found in the arsenals of our commensal bacteria.

Sep 11, 2014, 12:05 PM by Michael Croft

Bio-IT World | The old Roche 454 facility in Branford, Connecticut, will soon be returning to genomic science, as the Icahn Institute at Mount Sinai prepares to set up its second sequencing facility on grounds abandoned by Roche in its shutdown of 454 Life Sciences.

Sep 11, 2014, 00:00 AM by Michael Croft

BOULDER, CO, UNITED STATES - Sep 11, 2014 - Array BioPharma Inc. (NASDAQ: ARRY), a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients with cancer, today announced the appointment of Victor Sandor, M